Literature DB >> 7879680

Immunotherapy and gene therapy of cancer.

S E Ettinghausen1, S A Rosenberg.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7879680

Source DB:  PubMed          Journal:  Adv Surg        ISSN： 0065-3411


× No keyword cloud information.
  6 in total

Review 1.  Recent advances in the treatment of malignant melanoma with gene therapy.

Authors:  E M Hersh; A T Stopeck
Journal:  Mol Med       Date:  1997-10       Impact factor: 6.354

2.  Signals from lymphocytes in colon cancer.

Authors:  R Kiessling
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

3.  A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire.

Authors:  F M Batliwalla; B A Bateman; D Serrano; D Murray; S Macphail; V C Maino; J C Ansel; P K Gregersen; C A Armstrong
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

4.  Induction of anti-tumour lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytes.

Authors:  C N Baxevanis; M L Tsiatas; N T Cacoullos; G Spanakos; C Liacos; I Missitzis; S I Papadhimitriou; M Papamichail
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Modulation of colony stimulating factor release and apoptosis in human colon cancer cells by anticancer drugs.

Authors:  S Calatayud; T D Warner; J A Mitchell
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

6.  The in vitro and in vivo anti-melanoma effects of hydroxyapatite nanoparticles: influences of material factors.

Authors:  Hongfeng Wu; Zhongtao Li; Jiaoqing Tang; Xiao Yang; Yong Zhou; Bo Guo; Lin Wang; Xiangdong Zhu; Chongqi Tu; Xingdong Zhang
Journal:  Int J Nanomedicine       Date:  2019-02-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.